Rubius Therapeutics Inc. (RUBY)
NASDAQ: RUBY
· Real-Time Price · USD
0.06
0.00 (8.11%)
At close: Dec 29, 2023, 9:49 PM
Rubius Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -155.48M | -209.08M | -197.54M | -204.56M | -194.62M | -180.6M | -170.74M | -158.51M |
Interest Income | 819K | 711K | 342K | 113K | 91K | 153K | 353K | 737K |
Pretax Income | -179.67M | -214.55M | -200.69M | -206.63M | -196.55M | -182.06M | -173.9M | -161.57M |
Net Income | -233.75M | -247.48M | -203.57M | -208.18M | -196.55M | -182.06M | -173.9M | -161.57M |
Selling & General & Admin | 30.84M | 43.67M | 48.41M | 52.35M | 53.03M | 53.23M | 53.17M | 50.92M |
Research & Development | 96.41M | 135.35M | 149.13M | 152.21M | 141.59M | 127.38M | 117.57M | 107.6M |
Other Expenses | 1.82M | -1.17M | 1.5M | 2.49M | 2.77M | 3.24M | 799K | 31K |
Operating Expenses | 127.25M | 179.03M | 197.54M | 204.56M | 194.62M | 180.6M | 170.74M | 158.51M |
Interest Expense | 3.86M | 6.66M | 6.63M | 6.32M | 6.43M | 5.97M | 5.43M | 4.95M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 127.25M | 179.03M | 197.54M | 204.56M | 194.62M | 180.6M | 170.74M | 158.51M |
Income Tax Expense | 54.08M | 34.6M | 8.98M | 9.99M | 10.49M | 8.31M | 5.34M | 4.09M |
Shares Outstanding (Basic) | 90.43M | 90.36M | 90.26M | 90.15M | 89.92M | 89.81M | 89.52M | 82.31M |
Shares Outstanding (Diluted) | 90.43M | 90.36M | 90.26M | 90.15M | 89.92M | 89.81M | 89.52M | 82.31M |
EPS (Basic) | -2.59 | -2.74 | -2.26 | -2.32 | -2.23 | -2.12 | -2.08 | -1.99 |
EPS (Diluted) | -2.59 | -2.74 | -2.26 | -2.32 | -2.23 | -2.12 | -2.08 | -1.99 |
EBITDA | -180.44M | -205.54M | -189.95M | -196.29M | -186.15M | -172.14M | -164.22M | -152.12M |
EBIT | -175.24M | -205.96M | -192.13M | -198.38M | -188.18M | -174.81M | -167.19M | -155.34M |
Depreciation & Amortization | 37.13M | 40.09M | 8.24M | 7.87M | 7.72M | 4.85M | 5.14M | 5.4M |